Science Explorer Back to mapMap
Discussion
Hospital / health system · Denver · United States

Rocky Mountain Cancer Centers

In research, Rocky Mountain Cancer Centers stands highest in Health Sciences (#9,028 of 16,688 worldwide) and Medicine (#9,217 of 14,558 worldwide), over all time. Relative to its size it is most specialised in Medicine (Medicine is 4.2× its share of world research).

rockymountaincancercenters.comROR OpenAlex
World rank, all time
#31,009
of 34,923
Rank in United States
#6,550
of 7,310
Research works
208
▲ 20% vs 2018-21
Citations
4.6k
22.0 per fractional work
Top-10% rate
14.3%
all institutions 10.0%
vs its own fields
0.98×
1.00× is exactly expected
Open access
29%
world 40%
International
26%
world 18%
Rocky Mountain Cancer Centers

What is Rocky Mountain Cancer Centers known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #9,028 of 16,688 13.5%162
MedicineField #9,217 of 14,558 13.5%159

Each strip is that field's whole ranked pool, with the notch where Rocky Mountain Cancer Centers sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Rocky Mountain Cancer Centers work in?

In 2022-now, 82% of research at Rocky Mountain Cancer Centers is in Health Sciences, 12% in Life Sciences. Its largest fields are Medicine (81%), Biochemistry, Genetics and Molecular Biology (9%), Economics, Econometrics and Finance (4%). It does 3.1× the world's share of Health Sciences.

Health Sciences: 48 fractional works · 82.0% of its workMedicine: 47 fractional works · 80.8% of its workOncology: 13 fractional works · 21.7% of its workPathology and Forensic Medicine: 6 fractional works · 11.1% of its workGenetics: 6 fractional works · 10.8% of its workPulmonary and Respiratory Medicine: 6 fractional works · 9.5% of its workHematology: 4 fractional works · 7.1% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 4.0% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 3.3% of its workSurgery: 2 fractional works · 3.3% of its workEpidemiology: 2 fractional works · 3.2% of its workDermatology: 1 fractional works · 1.0% of its workNeurology: 1 fractional works · 1.0% of its workGastroenterology: 0 fractional works · 0.7% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.5% of its workRheumatology: 0 fractional works · 0.5% of its workFamily Practice: 0 fractional works · 0.4% of its workOtorhinolaryngology: 0 fractional works · 0.4% of its workObstetrics and Gynecology: 0 fractional works · 0.4% of its workRehabilitation: 0 fractional works · 0.3% of its workInfectious Diseases: 0 fractional works · 0.2% of its workInternal Medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 1.2% of its workHealth Professions: 1 fractional works · 0.9% of its workGeneral Health Professions: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 0.3% of its workNutrition and Dietetics: 0 fractional works · 0.3% of its workLife Sciences: 7 fractional works · 11.9% of its workBiochemistry, Genetics and Molecular Biology: 5 fractional works · 9.0% of its workMolecular Biology: 2 fractional works · 3.5% of its workGenetics: 2 fractional works · 2.6% of its workCancer Research: 1 fractional works · 2.3% of its workCell Biology: 0 fractional works · 0.3% of its workBiotechnology: 0 fractional works · 0.3% of its workImmunology and Microbiology: 1 fractional works · 2.4% of its workImmunology: 1 fractional works · 2.4% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.3% of its workPharmacology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 0 fractional works · 0.1% of its workSocial Sciences: 3 fractional works · 4.7% of its workEconomics, Econometrics and Finance: 3 fractional works · 4.3% of its workEconomics and Econometrics: 3 fractional works · 4.3% of its workSocial Sciences: 0 fractional works · 0.2% of its workSociology and Political Science: 0 fractional works · 0.2% of its workPsychology: 0 fractional works · 0.2% of its workPhysical Sciences: 1 fractional works · 1.4% of its workChemistry: 0 fractional works · 0.7% of its workOrganic Chemistry: 0 fractional works · 0.7% of its workPhysics and Astronomy: 0 fractional works · 0.3% of its workRadiation: 0 fractional works · 0.3% of its workEnvironmental Science: 0 fractional works · 0.1% of its workMathematics: 0 fractional works · 0.1% of its workEngineering: 0 fractional works · 0.1% of its workMaterials Science: 0 fractional works · 0.1% of its workALL ITS WORKRocky MountainCancer Centers59fractional works, 2022-now
Life Sciences12%Physical Sciences1%Health Sciences82%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Medicine4780.8%
    2. Health Professions10.9%
    3. Nursing00.3%
    1. Biochemistry, Genetics and Molecular Biology59.0%
    2. Immunology and Microbiology12.4%
    3. Pharmacology, Toxicology and Pharmaceutics00.3%
    4. Neuroscience00.1%
    1. Economics, Econometrics and Finance34.3%
    2. Social Sciences00.2%
    3. Psychology00.2%
    1. Chemistry00.7%
    2. Physics and Astronomy00.3%
    3. Environmental Science00.1%
    4. Mathematics00.1%
    5. Engineering00.1%
    6. Materials Science00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Rocky Mountain Cancer Centers specialise in?

Where its research is concentrated relative to its size: Medicine takes 4.2× the share of its output that it takes of world research.

  1. MedicineField · 47.3 works4.2×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.69× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 2.38× its world share, 1 worksImmunology and Micro…Neuroscience: 0.07× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.96× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.45× its world share, 0 worksChemistryEnvironmental Science: 0.03× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.02× its world share, 0 worksMaterials ScienceMathematics: 0.12× its world share, 0 worksMathematicsPhysics and Astronomy: 0.15× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.34× its world share, 0 worksHealth ProfessionsMedicine: 4.20× its world share, 47 worksMedicineNursing: 0.58× its world share, 0 worksNursingEconomics, Econometrics and Finance: 2.00× its world share, 2 worksEconomics, Econometr…Psychology: 0.06× its world share, 0 worksPsychologySocial Sciences: 0.02× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.2×. Every wedge is a field page.

All 15 fields, with their numbers
  1. Medicine4.20×47 works
  2. Immunology and Microbiology2.38×1 works
  3. Economics, Econometrics and Finance2.00×2 works
  4. Biochemistry, Genetics and Molecular Biology1.69×5 works
  5. Pharmacology, Toxicology and Pharmaceutics0.96×0 works
  6. Nursing0.58×0 works
  7. Chemistry0.45×0 works
  8. Health Professions0.34×0 works
  9. Physics and Astronomy0.15×0 works
  10. Mathematics0.12×0 works
  11. Neuroscience0.07×0 works
  12. Psychology0.06×0 works
  13. Environmental Science0.03×0 works
  14. Materials Science0.02×0 works
  15. Social Sciences0.02×0 works

Who are the top researchers at Rocky Mountain Cancer Centers?

Ranked on the quality score, Allen Lee Cohn, Robert M. Jotte and John M. Burke lead among researchers whose main affiliation is Rocky Mountain Cancer Centers.

  1. 1 Allen Lee Cohn United States · #78,721 worldwide 16k citations · 233 works
  2. 2 Robert M. Jotte United States · #310,259 worldwide 15k citations · 186 works
  3. 3 John M. Burke United States · #330,530 worldwide 7.8k citations · 318 works
  4. 4 Arvind Chaudhry United States · #349,499 worldwide 5.2k citations · 79 works
  5. 5 Sami Diab United States · #506,550 worldwide 5.5k citations · 101 works
  6. 6 Ling Ma United States · #533,181 worldwide 4k citations · 41 works
  7. 7 Devchand Paul United States · #830,027 worldwide 2.5k citations · 57 works
  8. 8 Manojkumar Bupathi United States · #975,055 worldwide 1.4k citations · 92 works
  9. 9 Michael W. Meshad United States · #1,052,718 worldwide 2.3k citations · 19 works
  10. 10 David Jacob Andorsky United States · #1,375,633 worldwide 2.6k citations · 129 works
All ranked researchers at Rocky Mountain Cancer Centers

What are the most cited papers from Rocky Mountain Cancer Centers?

The most cited paper from Rocky Mountain Cancer Centers is "Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC" (Mark A. Socinski, Robert M. Jotte, Federico Cappuzzo et al., 2018), with 3,816 citations. Next come "Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma" (3,488) and "Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer" (1,671).

Most cited papers
#PaperReleasedCitations
1 Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC Mark A. Socinski, Robert M. Jotte, Federico Cappuzzo et al. · New England Journal of Medicine Open access 4 Jun 2018 3,816
2 Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma Brian I. Rini et al. · New England Journal of Medicine Open access 16 Feb 2019 3,488
3 Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer Aditya Bardia et al. · New England Journal of Medicine Open access 21 Apr 2021 1,671
4 Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA M.C. Liu et al. · Annals of Oncology Open access159 authors 30 Mar 2020 1,567
5 Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial Elizabeth M. Swisher et al. · The Lancet Oncology Open access 28 Nov 2016 1,218
All 60 most cited papers, with filters and sorting

Which keywords describe research at Rocky Mountain Cancer Centers?

By fractional works in 2022-now, weighted toward what it does more of than the world: Rituximab, Prognostic Factors, Lymphoma, PET Imaging, Immunotherapy, Gene Expression Profiling, Molecular Profiling and Classification.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Rituximab12▲ 139×2 topics
  2. Prognostic Factors10▲ 39×10 topics
  3. Lymphoma10▲ 105×3 topics
  4. PET Imaging8▲ 76×4 topics
  5. Immunotherapy7▲ 16×11 topics
  6. Classification6▲ 24×2 topics
  7. Gene Expression Profiling6▲ 140×2 topics
  8. Molecular Profiling6▲ 116×2 topics
  9. Genetic Pathogenesis6▲ 203×1 topic
  10. Hodgkin's Lymphoma6▲ 203×1 topic
  11. Chemotherapy6▲ 14×16 topics
  12. Chronic Lymphocytic Leukemia6▲ 227×1 topic
  13. Genomic Aberrations6▲ 227×1 topic
  14. Therapeutic Targets6▲ 63×3 topics
  15. Targeted Therapy4▲ 35×4 topics
  16. Clinical Trials4▲ 10×8 topics
  17. Cancer Immunotherapy4▲ 44×3 topics
  18. Breast Cancer4▲ 24×5 topics
  19. Tumor Regression4▲ 56×2 topics
  20. CAR T Cells4▲ 82×1 topic
  21. Chimeric Antigen Receptor4▲ 82×1 topic
  22. Leukemia4▲ 73×2 topics
  23. Minimal Residual Disease3▲ 68×2 topics
  24. Genomic Profiling2▲ 42×2 topics
  25. Tumor Microenvironment2▲ 8.9×7 topics
  26. Metastasis2▲ 11×8 topics
  27. Genetic Mutations2▲ 8.5×8 topics
  28. ALK Inhibitors2▲ 58×1 topic
  29. BCR-ABL2▲ 136×1 topic
  30. EGFR Mutations2▲ 58×1 topic
  31. Imatinib2▲ 136×1 topic
  32. Precision Medicine2▲ 7.1×3 topics
  33. Treatment Guidelines2▲ 17×2 topics
  34. Survival Analysis2▲ 12×5 topics
  35. Metastatic Breast Cancer2▲ 53×2 topics
  36. Monoclonal Antibodies2▲ 34×2 topics
  37. Neoadjuvant Therapy2▲ 13×4 topics
  38. Radiotherapy2▲ 7.6×7 topics
  39. Staging System2▲ 49×2 topics
  40. Molecular Characterization2▲ 15×4 topics

Which research topics does Rocky Mountain Cancer Centers publish most on?

By volume in 2022-now: Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research and Lung Cancer Treatments and Mutations.

Lymphoma Diagnosis and T…6Lymphoma Diagnosis and Treatment: 6 fractional worksChronic Lymphocytic Leuk…6Chronic Lymphocytic Leukemia Research: 6 fractional worksCAR-T cell therapy research: 4 fractional worksLung Cancer Treatments a…2Lung Cancer Treatments and Mutations: 2 fractional worksChronic Myeloid Leukemia…2Chronic Myeloid Leukemia Treatments: 2 fractional worksCancer Immunotherapy and…2Cancer Immunotherapy and Biomarkers: 2 fractional worksEconomic and Financial Impacts of Cancer: 2 fractional worksMultiple Myeloma Research and Treatments: 1 fractional worksBRCA gene mutations in cancer: 1 fractional worksAcute Lymphoblastic Leukemia research: 1 fractional works
Pathology and Forensic MedicineGeneticsOncologyPulmonary and Respiratory Medicine3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 6 works
  2. 2 Chronic Lymphocytic Leukemia Research Genetics 6 works
  3. 3 CAR-T cell therapy research Oncology 4 works
  4. 4 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
  5. 5 Chronic Myeloid Leukemia Treatments Hematology 2 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 2 works
  7. 7 Economic and Financial Impacts of Cancer Economics and Econometrics 2 works
  8. 8 Multiple Myeloma Research and Treatments Hematology 1 works
  9. 9 BRCA gene mutations in cancer Genetics 1 works
  10. 10 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available29.0%not open71.0%

World: 40% of research is openly available.

with international co-authors25.6%domestic only74.4%

World: 18% is written across borders.

How has Rocky Mountain Cancer Centers's research output changed?

Output in 2022-2025 was 20% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Rocky Mountain Cancer Centers as a percentage of every work published that year, 0.00027% in 2024.

still counting0.00020%0.00040%Rocky Mountain Cancer Centers0.00019% in 20251990200020102020

Fractional works of Rocky Mountain Cancer Centers over all fractional works that year. How the balance of science has shifted.

Other research institutions in Denver

All research institutions in Denver

Share Rocky Mountain Cancer Centers's ranking

Rocky Mountain Cancer Centers on Science Explorer

A card with Rocky Mountain Cancer Centers's standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Rocky Mountain Cancer Centers. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.